Enlaza Therapeutics Announces Strategic Collaboration with Vertex Pharmaceuticals to Develop War-Lock Drug Conjugates and T-Cell Engagers for Improved Conditioning and Certain Autoimmune DiseasesBusiness Wire • 09/02/25
Undercovered Dozen: BrightSpire Capital, Vertex Pharmaceuticals, Adobe And MoreSeeking Alpha • 08/18/25
7 Reasons Why Vertex Pharmaceuticals Is a No-Brainer Stock to Buy on the DipThe Motley Fool • 08/06/25
Inspire Medical Systems, Ichor Holdings, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market SessionBenzinga • 08/05/25
Compared to Estimates, Vertex (VRTX) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/04/25
Vertex Pharmaceuticals (VRTX) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/04/25